임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

26건 표시

1상모집 중· Prostate Cancer
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
리드: 리제네론
상세 →NCT07543055
1상모집 예정· Nasopharyngeal Carcinoma
A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma
협력: 리제네론
상세 →NCT07650266
1상모집 예정· Hepatocellular Carcinoma
Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma
협력: 리제네론
상세 →NCT07365839
1상모집 중· Overweight or Obesity
Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
리드: 리제네론
상세 →NCT07594093
1상모집 중· Healthy Volunteers
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy Participants
리드: 사노피 · 협력: 리제네론
상세 →NCT07646548
1상모집 중· Healthy Volunteer
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
리드: 리제네론
상세 →NCT07527923
1상모집 예정· Healthy Volunteer
A First in Human Study to Assess Safety, Tolerability and Pharmacokinetics of a Single Dose of REGN22044 in Healthy Adults
리드: 리제네론
상세 →NCT07526116
1상모집 중· Geographic Atrophy (GA)
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
리드: 리제네론
상세 →NCT07230834
1상모집 중· Lupus Nephritis (LN)
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
리드: 리제네론
상세 →NCT06975787
1상모집 중· Parkinsons Disease
First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
리드: 리제네론
상세 →NCT07216066
1상모집 중· Alzheimer's Disease
A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
협력: 리제네론
상세 →NCT07214727
1상모집 중· Prostate Cancer
A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
협력: 리제네론
상세 →NCT06826768
1상모집 중· Anaplastic Thyroid Cancer
XL092 and Cemiplimab in BRAF WT Thyroid Cancer
협력: 리제네론
상세 →NCT06902376
1상모집 중단 (진행 중)· Healthy Volunteer
Phase 1 Safety and Tolerability Study of ALN-F1202 in Healthy Adults
리드: 리제네론
상세 →NCT06669234
1상모집 중· Epithelial Ovarian Cancer
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
리드: 리제네론
상세 →NCT06469281
1상모집 중단 (진행 중)· Healthy Volunteers With Hyperlipidemia
A First In Human (FIH) Study to Learn if Different Doses of ALN-ANG3 Are Safe and Well Tolerated in Healthy Adults
리드: 리제네론
상세 →NCT06452771
1상모집 중단 (진행 중)· Food Allergy
Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy
리드: 리제네론
상세 →NCT06369467
1상모집 중단 (진행 중)· Lung Cancer
A Phase Ib Study to Evaluate the Safety and Preliminary Efficacy of IL6-receptor Antibody Sarilumab in Combination With antiPD1 Antibody Cemiplimab for Patients With Non-small Cell Lung Cancer.
협력: 리제네론
상세 →NCT05704634
1상모집 중· B-cell Non-Hodgkins Lymphoma (B-NHL)
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
리드: 리제네론
상세 →NCT05685173
1상모집 중· Advanced Solid Tumor
A Study of ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants With Solid Cancers Treated With Cemiplimab
리드: 리제네론
상세 →NCT05259709
1상모집 중· Multiple Myeloma
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
리드: 리제네론
상세 →NCT05137054
1상초청 등록· Locally Advanced Head and Neck Squamous Cell Carcinoma
Study of Cemiplimab - TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
협력: 리제네론
상세 →NCT05376553
1상모집 중· Acute Myeloid Leukemia
PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML
협력: 리제네론
상세 →NCT05105152
1상모집 중· Merkel Cell Carcinoma
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
협력: 리제네론, 사노피
상세 →NCT04975152
1상모집 중· Head and Neck Cancer
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
협력: 리제네론
상세 →NCT04722523
1상모집 중단 (진행 중)· Advanced Malignancies
Safety and Pharmacokinetics of Cemiplimab Anti-programmed Death-ligand 1 (Anti-PD-1) and Other Agents in Japanese Adult Patients With Advanced Malignancies
리드: 리제네론
상세 →NCT03233139

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.